2002
DOI: 10.1128/iai.70.12.6811-6816.2002
|View full text |Cite
|
Sign up to set email alerts
|

Immunization with the N-Terminal Portion ofTreponema pallidumRepeat Protein K Attenuates Syphilitic Lesion Development in the Rabbit Model

Abstract: When used as an immunogen, Treponema pallidum repeat protein K (TprK) has been shown to attenuate syphilitic lesions upon homologous intradermal challenge in the rabbit model. To further explore this protein as a potential vaccine component, we sought to identify the immunogenic regions of TprK. The abilities of three recombinant peptides encompassing TprK to elicit T-and B-cell responses and to protect against challenge were examined. All three fragments elicited proliferative responses from splenocytes taken… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
64
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 69 publications
(67 citation statements)
references
References 40 publications
3
64
0
Order By: Relevance
“…This protocol was very cumbersome and expensive, and impractical to test in humans. Immunization with recombinant T. pallidum antigens can stimulate production of an immune response in the rabbit model, resulting in only partial protection, with significantly attenuated lesion development but no sterile immunity (80,83,(142)(143)(144)(145). The discovery of antigenic variation in TprK makes the development of a protective vaccine even more formidable.…”
Section: Vaccine Development and Preventionmentioning
confidence: 99%
See 1 more Smart Citation
“…This protocol was very cumbersome and expensive, and impractical to test in humans. Immunization with recombinant T. pallidum antigens can stimulate production of an immune response in the rabbit model, resulting in only partial protection, with significantly attenuated lesion development but no sterile immunity (80,83,(142)(143)(144)(145). The discovery of antigenic variation in TprK makes the development of a protective vaccine even more formidable.…”
Section: Vaccine Development and Preventionmentioning
confidence: 99%
“…Among Tpr family members, TprK is the best studied. A strong antibody and T cell immune response is elicited against TprK (81,82), and immunization with recombinant TprK provides partial immunity against infectious challenge (80,83). Antibodies raised against recombinant TprK can opsonize T. pallidum for phagocytosis by macrophages in vitro (80).…”
Section: The Natural History Of Syphilis Primary Syphilis -Transmissimentioning
confidence: 99%
“…Although major T-cell antigens include T. pallidum lipoproteins and endoflagellar polypeptides, TprK, TprI, and the amino-terminal conserved subfamily I peptide were also shown to be strong targets for the cellular component of the immune response (17,19,22), emphasizing again the importance of these antigens in the immune response to syphilis infection.…”
mentioning
confidence: 99%
“…Although the function of the Tprs is still unknown and attempts to determine the cellular location of TprI and TprK have resulted in controversial results (10,12), several studies have highlighted the importance of these antigens during the immune response to syphilis in the rabbit model (17,19,22). Immunization with recombinant peptides based on TprI, TprF, and TprK sequences significantly alters lesion development after intradermal challenge (3,10,22); moreover, TprK possesses multiple alleles in T. pallidum isolates, conferring an impressive potential for antigenic variation and, consequently, of immune evasion (4,5).…”
mentioning
confidence: 99%
See 1 more Smart Citation